Dr. Kalinsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-778-1900Fax+1 212-305-0178
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2009
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
- Tufts Medical CenterResidency, Internal Medicine, 2002 - 2005
- Medical University of South CarolinaClass of 2002
Certifications & Licensure
- GA State Medical License 2020 - 2025
- NY State Medical License 2008 - 2025
- MA State Medical License 2006 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2009 Jul 02
- Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer Start of enrollment: 2009 Sep 01
- Adjuvant Valproate for High Grade Sarcomas Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsAbemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial.Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, Stephanie L Graff, Kyong Hwa Park
Journal of Clinical Oncology. 2025-03-20 - 1 citationsDevelopment and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.Lajos Pusztai, Jess R Hoag, Kathy S Albain, William E Barlow, Salomon M Stemmer
Journal of Clinical Oncology. 2025-03-10 - Comprehensive Molecular and Genomic Analysis of NCI-MATCH Subprotocol Y: Capivasertib in Patients With an-Mutated Tumor.Carolyn K McCourt, Jacob Gross, Kevin Kalinsky, Ping Guan, Lisa M McShane
JCO Precision Oncology. 2025-03-01
Journal Articles
- Effect of Capivasertib in Patients with an AKT1 E17K-Mutated TumorKevin Kalinsky, Edith P Mitchell, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Alice P Chen, Keith T Flaherty, JAMA Oncology
Lectures
- Enhancing Checkpoint Inhibitors in Triple-Negative Breast Cancer. Breast Cancer Immunotherapy: Can We Crack the Code?2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Phase IB trial of ACY-1215 (Ricolinostat) combined with nab-paclitaxel in metastatic breast cancer.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
- New Chief Surgical Officer at Winship Cancer Institute of Emory University – Tari King, MDMarch 10th, 2025
- The Evolving Landscape of CDK4/6i Therapy in Metastatic Breast Cancer: Experts Discuss Key Findings and Future DirectionsMarch 9th, 2025
- RSClin Tool N+ Enhances Breast Cancer Risk EstimatesJanuary 23rd, 2025
- Join now to see all
Grant Support
- Breast Cancer Brain Metastasis Therapy by Focused Ultrasound-Guided Control of HER2 CAR T cellsGEORGIA INSTITUTE OF TECHNOLOGY2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: